跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/JPRN-UMIN000053576
JPRN-UMIN000053576尚未招募Unknown

ationwide survey on visceral AVMs associated with Osler's disease (Hereditary Hemorrhagic Telangiectasia) (a multi-center, retrospective study) - Nationwide survey on visceral AVMs associated with Osler's disease (HHT)

Keio University0 个研究点目标入组 500 人开始时间: 2024年2月14日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

试验速览

阶段
Unknown
状态
尚未招募
入组人数
500
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
ot applicable 至 ot applicable（—）
性别
All

入选标准

  • 未提供

排除标准

  • •1 Patients with insufficient medical information 2 Patients deemed inappropriate by the principal investigator or subinvestigator to conduct this study

研究者

相似试验

尚未招募
不适用
Measuring health vital signs and blood sugars with a wearable, noninvasive writstwatch
CTRI/2018/02/012074ifePlus
已完成
不适用
A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)Menopause
NCT04553029Astellas Pharma Singapore Pte. Ltd.3,399
尚未招募
2 期
A Phase II, Open-Label, Multicenter Study of Vemurafenib plus Cobimetinib (GDC-0973) in Unresectable Stage IIIc or Stage IV Melanoma; Response Monitoring and Resistance Prediction with Positron Emission Tomography and Tumor Characteristics.10040900melanomaskin cancer
NL-OMON44689Werkgroep Immunotherapie Nederland voor Oncologie (WIN-O)90
进行中（未招募）
不适用
A Multicenter Study of Vemurafenib plus Cobimetinib (GDC-0973) in Unresectable Stage IIIc or Metastatic Melanoma; Response Monitoring and Resistance Prediction with Positron Emission Tomography and Tumor Characteristics.BRAFV600-mutation positive patients with unresectable stage IIIc or IV melanoma.MedDRA version: 17.0Level: PTClassification code 10025671Term: Malignant melanoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: PTClassification code 10025670Term: Malignant melanoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2014-002480-15-NLThe Dutch Working Group on Immunotherapy of Oncology (WIN-O)
尚未招募
Unknown
umber of patients acquired infection on ventilator and its end result in an Indian setting
CTRI/2022/10/046167ot Applicable